Submit Deal

Submit Deal

Cover Image ROIVANT SCIENCES LTD

ROIVANT SCIENCES LTD

ROIVANT SCIENCES LTD

Deals Overview

Total Deals9

Valued Deals9

Total Value£ 20.40 B

Avg. Deal Size£ 2.27 B

Market Context

Senior Management

Matt Gline
CEO
Stephanie Lee
Office of CEO
Richard Pulik
CFO

Sort

roivant sciences ltd

HQ - Switzerland

Pharmaceuticals

30 Dec 2019

Investment Date

10%

Stake

£ 2.44 B

Deal Value

roivant sciences ltd

HQ - Switzerland

Pharmaceuticals

1 Oct 2021

Investment Date

100%

Stake

£ 5.28 B

Deal Value

ciox health

HQ - United States

IT Services: Other

28 Jul 2021

Investment Date

100%

Stake

£ 4.95 B

Deal Value

immunovant sciences ltd

HQ - United States

Biotechnology

2 Aug 2021

Investment Date

6%

Stake

£ 143 M

Deal Value

telavant holdings

HQ - United States

Biotechnology

14 Dec 2023

Investment Date

100%

Stake

£ 5.96 B

Deal Value

dermavant

HQ - United States

Biotechnology

28 Oct 2024

Investment Date

100%

Stake

£ 909 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - ROIVANT SCIENCES LTD